top of page
PATHOS TSUTSUMI PROJECT
”Tsutsumi
Pathology Library”
Yutaka Tsutsumi, M.D.
Program 2 Specimens for exams of certified pathologists
General 1~35
Gl 1~79
HBP 1~49
Vascular 1~46
Lung 1~98
Serosa 1~18
Gyne 1~85
MGen 1~25
Urinary 1~73
Neuro 1~63
Connect 1~60
Endo 1~54
Br 1~58
Hemato 1~102
Mediast 1~19
HN 1~49
Eye 1~11
Skin 1~186
Cyto-Inf 1~53
Cyto-General 1~59
Hematological disorders : DPE-Hemato 1~102
DPE-Hemato-1_Rx_3yr11moF_HE_Gaucher’s disease
DPE-Hemato-2_Au_30'sF_HE_onion-skin lesion in SLE
DPE-Hemato-3_Au_adultM_HE_extramedullary hematopoiesis
DPE-Hemato-4-1_Au_85F_HE_hidden functions of the spleen-1
DPE-Hemato-4-2_Au_85F_IHC (CD61)_hidden functions of the spleen-2
DPE-Hemato-5_Au_57M_HE_Gamna-Gandy nodules with splenic infarction
DPE-Hemato-6_Rx_13M_HE_hereditary spherocytosis
DPE-Hemato-7_Rx_9F_HE_idiopathic thrombocytopenic purpura in an accessory spleen
DPE-Hemato-8_Au_82M_HE_AA amyloidosis with SAA production in pancreatic acinar cells
DPE-Hemato-9_Rx_12F_HE_cat scratch disease (splenic suppurative granuloma)
DPE-Hemato-10_Au_46M_HE_EBV-associated hemophagocytic syndrome (EB-VAHS)
DPE-Hemato-11_Rx_65M_HE_Ascaris larva migration
DPE-Hemato-12_Rx_57F_HE_splenoma (splenic hamartoma)
DPE-Hemato-13_Rx_23M_HE_chronic myeloid leukemia
DPE-Hemato-14_Rx_66M_HE_hairy cell leukemia
DPE-Hemato-15_Rx_44M_HE_splenic follicular lymphoma
DPE-Hemato-16_Asp_49M_HE_miliary tuberculosis
DPE-Hemato-17_Bx_72M_HE_striated histiocytes in Mycobacterium avium-intracellulare infection after steroid administration
DPE-Hemato-18_Bx_35F_HE_idiopathic thrombocytopenic purpura
DPE-Hemato-19_Asp_25F_HE_hypereosinophilic syndrome
DPE-Hemato-20_Bx_33M_HE_pure red cell aplasia provoked after erythema infectiosum (parvovirus B19 infection)
DPE-Hemato-21_Asp_26F_HE_autoimmune hemolytic anemia (erythroid hyperplasia)
DPE-Hemato-22_Asp_86F_HE_aplastic anemia
DPE-Hemato-23_Asp_82F_HE_megaloblastic anemia
DPE-Hemato-24_Asp_25M_HE_hemophagocytic syndrome
DPE-Hemato-25_Bx_74M_HE_myelodysplastic syndrome (MDS) with reticulin fibrosis
DPE-Hemato-26_Asp_33F_HE_AML (M2)
DPE-Hemato-27_Asp_34M_HE_APL (M3) with numerous faggot cells
DPE-Hemato-28_Asp_73M_HE_erythroleukemia (M6)
DPE-Hemato-29_Bx_10'sM_HE_B-ALL
DPE-Hemato-30_Asp_55M_HE_B-CLL
DPE-Hemato-31_Bx_52M_HE_hairy cell leukemia
DPE-Hemato-32_Asp_57F_HE_adult T-cell leukemia
DPE-Hemato-33_Bx_34M_HE_primary myelofibrosis
DPE-Hemato-34_Bx_87F_HE_essential thrombocythemia
DPE-Hemato-35_Bx_63F_HE_chronic myeloid leukemia (CML)
DPE-Hemato-36_Asp_74F_HE_chronic myeloid leukemia, lymphoid crisis
DPE-Hemato-37_Au_74M_HE_chronic neutrophilic leukemia
DPE-Hemato-38_Asp_82F_HE_multiple myeloma, flame cell type, IgA, kappa-type
DPE-Hemato-39_Asp_77M_HE_multiple myeloma, IgG, lambda-type, with Russell body formation
DPE-Hemato-40_Asp_67M_HE_multiple myeloma, IgG, kappa-type with cryoglobulin deposition
DPE-Hemato-41_Asp_65M_HE_Waldenström macroglobulinemia, IgM, kappa-type
DPE-Hemato-42_Asp_71M_HE_mantle cell lymphoma with bone marrow involvement
DPE-Hemato-43_Asp_54M_HE_T-cell lymphoma, hemophagocytic lymphohistiocytosis-type
DPE-Hemato-44_Asp_79M_HE_blastic plasmacytoid dendritic cell neoplasm
DPE-Hemato-45_Asp_1moM_HE_Letterer-Siwe disease
DPE-Hemato-46_Asp_37M_HE_metastatic signet ring cell carcinoma
DPE-Hemato-47_Bx_82M_HE_metastatic prostatic adenocarcinoma
DPE-Hemato-48_Bx_78F_HE_reactive lymphadenopathy
DPE-Hemato-49_Bx_32F_HE_monocytoid B-cell hyperplasia
DPE-Hemato-50_Bx_43F_HE_endosalpingiosis
DPE-Hemato-51_Bx_53F_HE_cat scratch disease (bartonellosis)
DPE-Hemato-52_Ex_67F_HE_tuberculous lymphadenitis
DPE-Hemato-53_Ex_76M_HE_disseminated BCG infection (S/P: BCG intravesical instillation therapy against urinary bladder cancer)
DPE-Hemato-54_Au_35M_HE_nodal cryptococcosis in AIDS
DPE-Hemato-55_Bx_20'sM_HE_measles lymphadenitis
DPE-Hemato-56_Bx_18M_HE_infectious mononucleosis
DPE-Hemato-57_Au_30'sM_HE_lymphadenopathy in AIDS
DPE-Hemato-58_Bx_40'sM_HE_Toxoplasma lymphadenitis
DPE-Hemato-59_Bx_32F_HE_reactive lymphadenopathy, Piringer-Kuchinka type
DPE-Hemato-60_Bx_61F_HE_sarcoidosis with asteroid bodies
DPE-Hemato-61_Bx_61F_HE_sarcoid-like reaction with metastatic papillary thyroid carcinoma
DPE-Hemato-62_Bx_39M_HE_coagulation necrosis with angiitis in SLE
DPE-Hemato-63_Bx_35F_HE_subacute necrotizing lymphadenitis (Kikuchi-Fujimoto)
DPE-Hemato-64_Ex_20'sM_HE_sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman)
DPE-Hemato-65_Bx_63F_HE_progressive transformation of germinal centers
DPE-Hemato-66_Bx_14F_HE_Castleman's disease, hyaline vascular type
DPE-Hemato-67_Bx_52F_HE_Castleman's disease, multicentric plasma cell type
DPE-Hemato-68_Bx_47F_HE_Castleman's disease manifesting TAFRO syndrome
DPE-Hemato-69_Bx_36M_HE_dermatopathic lymphadenopathy
DPE-Hemato-70_Bx_58M_HE_methotrexate-associated lymphoproliferative disorder
DPE-Hemato-71_Bx_44M_HE_atypical paracortical hyperplasia
DPE-Hemato-72_Bx_59M_HE_mantle cell lymphoma
DPE-Hemato-73_Bx_56F_HE_MALT lymphoma with salivary gland components
DPE-Hemato-74_Bx_63F_HE_small B-cell lymphoma with proliferation centers
DPE-Hemato-75_Bx_64M_HE_follicular lymphoma, G1
DPE-Hemato-76_Bx_84M_HE_follicular lymphoma, G3A
DPE-Hemato-77_Bx_61M_HE_lymphoplasmacytic B-cell lymphoma with macroglobulinemia
DPE-Hemato-78_Bx_20M_HE_primay mediastinal large B-cell lymphoma
DPE-Hemato-79_Bx_89M_HE_diffuse large B-cell lymphoma, GCB type
DPE-Hemato-80_needle Bx_81F_HE_diffuse large B-cell lymphoma, ABC type
DPE-Hemato-81_Bx_82F_HE_EBV-positive diffuse large B-cell lymphoma
DPE-Hemato-82_Bx_86M_HE (skin)_EBV-positive mucocutaneous ulcer, plasmablastic type
DPE-Hemato-83_Bx_65M_HE_angioimmunoblastic T-cell lymphoma
DPE-Hemato-84_Bx_65M_HE_follicular helper T-cell lymphoma
DPE-Hemato-85_Bx_14M_HE_lymphoblastic lymphoma
DPE-Hemato-86_needle Bx_26F_HE_cytotoxic T-cell lymphoma, medium-sized
DPE-Hemato-87_Bx_46F_HE_peripheral T-cell lymphoma, medium-sized cell type
DPE-Hemato-88_Bx_84F_HE_CD4-positive peripheral T-cell lymphoma
DPE-Hemato-89_Bx_82F_HE_adult T-cell lymphoma, pleomorphic type
DPE-Hemato-90_Bx_77M_HE_anaplastic large cell lymphoma (Ki-1 lymphoma) with epithelioid appearance
DPE-Hemato-91_Bx_58M_HE_Lennert lymphoma
DPE-Hemato-92_Bx_45M_HE_Hodgkin lymphoma (NLPHL)
DPE-Hemato-93_Bx_70M_HE_Hodgkin lymphoma (LR), L&H-rich
DPE-Hemato-94_Bx_22F_HE_Hodgkin lymphoma (NS)
DPE-Hemato-95_Bx_63M_HE_Hodgkin lymphoma (MC)
DPE-Hemato-96_Bx_67M_HE_Hodgkin lymphoma (LD)
DPE-Hemato-97_Bx_19M_HE_Hodgkin-like B-cell lymphoma
DPE-Hemato-98_Bx_81F_HE_methotrexate-induced Hodgkin-like B-cell lymphoma
DPE-Hemato-99_Bx_69M_HE_follicular dendritic cell sarcoma
DPE-Hemato-100_Bx_51M_HE_histiocytic sarcoma (malignant lymphoma, true histiocytic)
DPE-Hemato-101_Bx_43M_HE_CML, myeloid blast crisis
DPE-Hemato-102_Bx_29F_HE_micrometastasis of breast cancer
Pr.2 TOP
HOME
about us
How to login
PDF & free programs
Pr.3
Pr.7 Inf-cytology
PDF ( Pr.1~Pr.23) free Program
programs for members only
Pr.6
Pr.6 Inf-coc 1~48
Pr.6 Inf-act 125~134
Pr.6 Inf-myco 135~160
Pr.6 Inf-spiro 161~177
Pr.6 Inf-chlam 178~183
Pr.6 Inf-rick 184~192
Pr.6 Inf-virus 249~353
Pr.6 Inf-prot 354~386
Pr.6 Inf-nemet 387~421
Pr.6 Inf-tremat 422~445
Pr.6 Inf-cest 446~457
Pr.6 Inf-arthro 458~471
Pr.6 Inf-others 472~494
Pr.23 Sk-Ecz 1～12
Pr.23 Sk-Lick 13～17
Pr.23 Sk-Pso 18～24
Pr.23 Sk-EM 25～29
Pr.23 Sk-Lymph 30～40
Pr.23 Sk-Neutro 41～46
Pr.23 Sk-Eosino 47～54
Pr.23 Sk-GVHG 55～61
Pr.23 Sk-Bull 62～76
Pr.23 Sk-Granul 77～100
Pr.23 Sk-Vascul 101～132
Pr.23 Sk-Pannic 133～137
Pr.23 Sk-Epid 138～158
Pr.23 Sk-Prot 360～365
Pr.23 Sk-Helm 366～376
Pr.23 Sk-Arth 377～388
Pr.23 Nevus 389～416
Pr.23 Sk-BENeo 417～431
Pr.23 Sk-MENeo 432～465
Pr.23 Sk-AdNeo 466～517
Pr.23 Sk-LPD 518～549
Pr.23 Sk-Leukemia 550～553
Pr.23 Sk-MNENeo 626～651
Pr.23 Sk-Met 652~664
More
Use tab to navigate through the menu items.
bottom of page